Although the enrichment of L-cells by pharmacological agents can be a novel approach for improving insulin secretion, glucose tolerance and the treatment of T2DM, more research for the specific differentiation of L-cells and the translation of in vitro and animal data to humans, are needed for the success of this approach
Sections were then blocked with dual endogenous enzyme-blocking reagent (DEEB, Agilent/Dako, S200389-2) (10 minutes) and Avidin/Biotin/Sniper (Vector, SP-2001) (3 minutes each) in turn, followed by mouse anti-glucagon (Abcam, ab10988) (1:1,000, 30 minutes) and goat anti-mouse AP conjugate (Biocare Medical, MALPH521H) (30 minutes), and detected using Ferangi Blue (Biocare Medical, FB813H) (2 minutes)
Reaching for anything above my head
It was originally approved by the U.S
In clinical trials, many patients do experience weight loss, but it is not guaranteed, and the amount of weight loss can differ from person to person